Junyuan Cao

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

Journal: Journal of virology
Published: April 21, 2026

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Journal: Signal transduction and targeted therapy
Published: September 25, 2025

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

Journal: Journal of virology
Published: September 16, 2025

A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.

A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.

Journal: PLoS pathogens
Published: September 05, 2025

Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2.

Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2.

Journal: Journal of medicinal chemistry
Published: May 22, 2025

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.

Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 25, 2025

Screening of botanical drugs reveals the potential anti-human adenovirus activity of berberine.

Screening of botanical drugs reveals the potential anti-human adenovirus activity of berberine.

Journal: Antiviral research
Published: October 11, 2024

Substrate recognition and cleavage mechanism of the monkeypox virus core protease.

Substrate recognition and cleavage mechanism of the monkeypox virus core protease.

Journal: Nature
Published: October 08, 2024

A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice.

A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice.

Journal: EBioMedicine
Published: April 08, 2023

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety.

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety.

Journal: Bioorganic & medicinal chemistry
Published: March 30, 2023

Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.

Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.

Journal: Antiviral research
Published: March 18, 2022

Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.

Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.

Journal: Viruses
Published: January 16, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026